Recent Developments in Dementia Treatment

The Food and Drug Administration (FDA) has recently granted full approval to a novel Alzheimer's treatment known as lecanemab. This medication has demonstrated the ability to moderately decelerate cognitive and functional decline in individuals with early-stage Alzheimer's disease. It received traditional approval from the US FDA for Alzheimer's disease treatment based on Phase 3 data derived from the Clarity AD clinical trial. Additionally, recent research suggests that older individuals with higher levels of triglycerides, a type of fat in the bloodstream, may experience a reduced risk of dementia and a slower cognitive decline over time when compared to those with lower triglyceride levels.

    Related Conference of Recent Developments in Dementia Treatment

    June 13-14, 2024

    37th European Neurology Congress 2024

    Rome, Italy
    June 27-28, 2024

    2nd International conference on Dementia

    London, UK
    June 27-28, 2024

    6th World Depression Congress

    Paris, France
    July 15-16, 2024

    7th World Conference on Neuroscience

    London, UK
    July 18-19, 2024

    36th World Conference on Neurology

    Paris, France
    July 22-23, 2024

    19th Annual Congress on Neuroscience

    Singapore City, Singapore
    August 13-14, 2024

    14th Global Alzheimers Summit

    Amsterdam, Netherlands
    August 16-17, 2024

    30th Annual Summit on Neuroscience & Neurological Disorders

    Melbourne, Australia
    August 26-27, 2024

    5th World Congress on Sleep Disorders and Therapeutics

    Singapore City, Singapore
    September 09-10, 2024

    2nd International conference on Neuro Surgery

    Paris, France
    September 19-20, 2024

    38th European Neurology Congress

    Paris, France
    September 23-24, 2024

    11th Annual congress on Stroke and Neurological Disorders

    Amsterdam, Netherlands
    October 23-24, 2024

    6th World Brain Congress

    Paris, France
    October 31-01, 2024

    7th Global Congress on Spine and Spinal Disorders

    Amsterdam, Netherlands
    October 31-01, 2024

    36th World Neuroscience and Neurology Conferences

    Amsterdam, Netherlands
    November 13-14, 2024

    31st Cognitive Neuroscience Congress

    Dubai, UAE
    November 26-27, 2024

    4th Annual Dementia Congress

    Paris, France
    December 05-06, 2024

    7th World Congress on Epilepsy and Brain Disorders

    Dubai, UAE
    December 05-06, 2024

    9th Annual Congress on Pediatric Neurology and Pediatric Surgery

    Prague, Czech Republic

    Recent Developments in Dementia Treatment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in